Search Results - Luis Ortega‐Paz

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial

    Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial by Luis Ortega-Paz, Claudio Laudani, Alessandro Sionis, Pablo Vidal-Cales, Victor Arevalos, Rut Andrea, Carlos Igor Morr, Oriol De Diego, Emilio Ortega, Francisco-Rafael Jimenez-Trinidad, Ana Paula Dantas, Dominick J. Angiolillo, Manel Sabaté, Jose T. Ortiz-Pérez, Salvatore Brugaletta

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    CYP2C19 Phenotype, P2Y12 Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy

    CYP2C19 Phenotype, P2Y12 Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy by Rajiv C. Patel, Cameron D. Thomas, Joseph S. Rossi, Francesco Franchi, Ellen C. Keeley, Amber L. Beitelshees, Julio D. Duarte, Luis Ortega‐Paz, Natasha Kulick, Marshall Winget, Anh B. Nguyen, William E. Yang, Sanjay Venkatesh, Dominick J. Angiolillo, Larisa H. Cavallari, Craig R. Lee, George A. Stouffer

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: